Potential value of heparin in COVID-19 related cardiovascular disease
Copyright © 2021 Elsevier Inc. All rights reserved..
There is increasing evidence that COVID-19 is a multi-organ infectious disease with respiratory system as its main clinical manifestation. In particular, its risk of cardiovascular infection calls for effective clinical intervention strategies. The multiple values of heparin in its cardiovascular system deserve to be considered.
| Errataetall: |
CommentOn: Am J Emerg Med. 2021 Aug;46:382-391. - PMID 33268238 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
The American journal of emergency medicine - 50(2021) vom: 15. Dez., Seite 789 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yu, Xianqiang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 13.12.2021 Date Revised 14.12.2021 published: Print-Electronic CommentOn: Am J Emerg Med. 2021 Aug;46:382-391. - PMID 33268238 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajem.2021.09.067 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331685914 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331685914 | ||
| 003 | DE-627 | ||
| 005 | 20231225214014.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajem.2021.09.067 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1105.xml |
| 035 | |a (DE-627)NLM331685914 | ||
| 035 | |a (NLM)34627645 | ||
| 035 | |a (PII)S0735-6757(21)00805-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yu, Xianqiang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Potential value of heparin in COVID-19 related cardiovascular disease |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.12.2021 | ||
| 500 | |a Date Revised 14.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Am J Emerg Med. 2021 Aug;46:382-391. - PMID 33268238 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a There is increasing evidence that COVID-19 is a multi-organ infectious disease with respiratory system as its main clinical manifestation. In particular, its risk of cardiovascular infection calls for effective clinical intervention strategies. The multiple values of heparin in its cardiovascular system deserve to be considered | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Cardiovascular system | |
| 650 | 4 | |a Heparin | |
| 650 | 7 | |a Heparin |2 NLM | |
| 650 | 7 | |a 9005-49-6 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t The American journal of emergency medicine |d 1986 |g 50(2021) vom: 15. Dez., Seite 789 |w (DE-627)NLM01297868X |x 1532-8171 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2021 |g day:15 |g month:12 |g pages:789 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajem.2021.09.067 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2021 |b 15 |c 12 |h 789 | ||